Syneos Health Inc (SYNH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SYNH Annual Cash Flow →
From Syneos Health Inc through Jun 30 2022, changes in Jun 30 2023's operating cash flow provide insight into underlying business performance trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
6 Months
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Operating Activities
Income-71.36
Depreciation & amortization120.92
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset0.00
Provision For Loan Losses Expensed6.76
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation38.83
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total10.42
Depreciation Depletion and Amortization Excluding Amortization of Financing Costs and Discounts-
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss-
Goodwill And Intangible Asset Impairment-
Depreciation and Amortization Excluding Amortization of Financing Costs and Discounts-
Stock Issuance Costs Operating Activities-
Increase Decrease In Accounts Receivable Contract With Customer Asset Net Current And Contract With Customer Liability Current-174.12
Income taxes-30.63
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities35.12
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-4.97
Other Noncash Income (Expense)17.09
Other net0.00
Payments for (Proceeds from) Other Operating Activities48.69
Discontinued operations0.00
Net Cash flow from Operating Activities-3.26
Investing Activities
Capital Expenditures-45.47
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Investments In Unconsolidated Affiliates-1.06
Payment Of Loans To Unconsolidated Affiliates-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Proceeds from Sales of Business, Affiliate and Productive Assets0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-46.53
Financing Activities
Short-term debt Net38.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock12.15
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-17.57
Repayments of Notes Payable And Breakage Fees-
Paymentsto Redeem Common Stock-
Repayments of Long Term Debt and Breakage Fees-
Finance Lease Principal Payments-6.44
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities26.15
Effect of exchange rate on cash flow-6.09
Discontinued operations0.00
Free Cash Flow-48.73
Total Cash Flow-29.73
4 historic quarters locked

Sign in to unlock the full Syneos Health Inc cash flow history.

About Syneos Health Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-039993

Figures are derived from filed reports and may be restated. Historical data is subject to revision.